Abstract
Cyclophilin A (CypA) was originally identified as a cytosolic protein possessing peptidyl–prolyl isomerase activity. CypA has been shown to play a pivotal role in the immune response, but little is known about other molecular mechanisms of CypA-mediated biologic events. In our present study, we demonstrate that knockdown CypA expression using RNAi in U2OS cells resulted in disruption of the F-actin structure, as well as decreased anchorage-independent growth, proliferation, and migration. Wild-type U2OS cells treated with cyclosporine A (CsA), a peptidyl–prolyl isomerase inhibitor, displayed the same phenotype as knockdown CypA cells, suggesting that the isomerase activity of CypA is required to maintain a normal phenotype. In vitro and in vivo binding assays revealed that CypA binds to N-WASP, which functions in the nucleation of actin via the Arp2/3 complex. Pulse-chase labeling study indicated an enhanced degradation of N-WASP in cell lacking CypA, suggesting that CypA is required for stabilizing N-WASP to form a N-WASP/Arp2/3 complex for the nucleation/initiation of F-actin polymerization.
Similar content being viewed by others
References
Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW (1984) Cyclophilin: a specific cytosolic binding protein for cyclosporine A. Science 226:544–547. doi:10.1126/science.6238408
Lang K, Schmid FX, Fischer G (1987) Catalysis of protein folding by prolyl isomerase. Nature 329:268–270. doi:10.1038/329268a0
Brazin KN, Mallis RJ, Fulton DB, Andreotti AH (2002) Regulation of the tyrosine kinase Itk by the peptidyl–prolyl isomerase cyclophilin A. Proc Natl Acad Sci USA 99:1899–1904. doi:10.1073/pnas.042529199
Bruns K, Fossen T, Wray V, Henklein P, Tessmer U, Schubert U (2003) Structural characterization of the HIV-1 Vpr N terminus: evidence of cis/trans-proline isomerism. J Biol Chem 278:43188–43201. doi:10.1074/jbc.M305413200
Nadeau K, Das A, Walsh CT (1993) HSP90 chaperonins possess ATPase activity, bind heat shock transcription factors, peptidyl–prolyl isomerases. J Biol Chem 268:1479–1487
Luban J (1996) Absconding with the chaperone: essential cyclophilin-Gag interaction in HIV-1 virions. Cell 87:1157–1159. doi:10.1016/S0092-8674(00)81811-5
Reddy PA, Atreya CD (1999) Identification of simian cyclophilin A as a calreticulin-binding protein in yeast two-hybrid screen and demonstration of cyclophilin A interaction with calreticulin. Int J Biol Macromol 25:345–351. doi:10.1016/S0141-8130(99)00053-7
Lu Y-C, Song J, Cho H-Y, Fan G, Yokoyama KK, Chiu R (2006) Cyclophilin A protects Peg3 from hypermethylation and inactive histone modification. J Biol Chem 281:39081–39087. doi:10.1074/jbc.M606687200
Piotukh K, Gu W, Kofler M, Labudde D, Helms V, Freund C (2005) Cyclophilin A binds to linear peptide motifs containing a consensus that is present in many human proteins. J Biol Chem 280:23668–23674. doi:10.1074/jbc.M503405200
Campa MJ, Wang MZ, Howard B, Fitzgerald MC, Patz EF Jr (2003) Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin A as potential molecular targets in non-small cell lung cancer. Cancer Res 63:1652–1656
Shen J, Person MD, Zhu J, Abbruzzese JL, Li D (2004) Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 64:9018–9026. doi:10.1158/0008-5472.CAN-04-3262
Lim SO, Park SJ, Kim W, Park SG, Kim HJ, Kim YI et al (2002) Proteome analysis of hepatocellular carcinoma. Biochem Biophys Res Commun 291:1031–1037. doi:10.1006/bbrc.2002.6547
Chen J, He QY, Yuen AP, Chiu JF (2004) Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. Proteomics 4:2465–2475. doi:10.1002/pmic.200300762
Rey O, Baluda MA, Park NH (1999) Differential gene expression in neoplastic and human papillomavirus-immortalized oral keratinocytes. Oncogene 18:827–831. doi:10.1038/sj.onc.1202328
Li Z, Zhao X, Bai S, Wang Z, Chen L, Wei Y, Huang C (2008) Proteomic identification of cyclophilin A as a potential prognostic factor and therapeutic target in endometrial carcinoma. Mol Cell Proteomics. doi:10.1074/mcp.M700544-MCP200
Buda A, Pignatelli M (2004) Cytoskeletal network in colon cancer: from genes to clinical application. Int J Biochem Cell Biol 36:759–765. doi:10.1016/j.biocel.2003.09.004
Erickson JW, Cerione RA (2001) Multiple roles for Cdc42 in cell regulation. Curr Opin Cell Biol 13:153–157. doi:10.1016/S0955-0674(00)00192-7
Higgs HN, Pollard TD (2001) Regulation of actin filament network formation through Arp2/3 complex: activation by a diverse array of proteins. Annu Rev Biochem 70:649–676. doi:10.1146/annurev.biochem.70.1.649
Ma L, Rohatgi R, Kirschner MW (1998) The Arp2/3 complex mediates actin polymerization induced by the small GTP-binding protein Cdc42. Proc Natl Acad Sci USA 95:15362–15367. doi:10.1073/pnas.95.26.15362
Hašková V, Rozprimova L, Hasek J, Jelinkova M (1994) Immunolocalization of cyclophilin in normal and cyclosporine A-treated human lymphocytes. Immunol Lett 41:267–272. doi:10.1016/0165-2478(94)90144-9
Kolcz J, Drukala J, Jurkiewicz A, Pfitzner R, Garlicki M, Czyz J et al (1999) Effects of cyclosporine A on contractile activity and cytoskeleton in chick embryo cardiomyocytes. Biochem Cell Biol 77:133–140. doi:10.1139/bcb-77-2-133
Song J, Lu Y-C, Yokoyama K, Rossi J, Chiu R (2004) Cyclophilin A is required for retinoic acid-induced neuronal differentiation in P19 cells. J Biol Chem 279:24414–24419. doi:10.1074/jbc.M311406200
Egile C, Loisel TP, Laurent V, Li R, Pantaloni D, Sansonetti PJ et al (1999) Activation of the Cdc42 effector N-WASP by the Shigella flexneri IcsA protein promotes actin nucleation by Arp2/3 complex and bacterial actin-based motility. J Cell Biol 146:1319–1332. doi:10.1083/jcb.146.6.1319
Rohatgi R, Nollau P, Ho HY, Kirschner MW, Mayer BJ (2001) Nck and phosphatidylinositol 4, 5-bisphosphate synergistically activate actin polymerization through the N-WASP-Arp2/3 pathway. J Biol Chem 276:26448–26452. doi:10.1074/jbc.M103856200
Howard B, Furumai R, Campa MJ, Rabbani ZN, Vujaskovic Z, Wang MZ, Patz EF Jr (2005) Stable RNA interference-mediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth in vivo. Cancer Res 65:8853–8860. doi:10.1158/0008-5472.CAN-05-1219
Ou WB, Luo W, Park YD, Zhou HM (2001) Chaperone-like activity of peptidyl–prolyl cis-trans isomerase during creatine kinase refolding. Protein Sci 10:2346–2353. doi:10.1110/ps.23301
Park SJ, Suetsugu S, Takenawa T (2005) Interaction of HSP90 to N-WASP leads to activation and protection from proteasome-dependent degradation. EMBO J 24:1557–1570. doi:10.1038/sj.emboj.7600586
Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345–357. doi:10.1016/S0092-8674(00)81279-9
Li M, Zhai Q, Bharadwaj U, Wang H, Li F, Fisher WE, Chen C, Yao Q (2006) Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer 106:2284–2294. doi:10.1002/cncr.21862
Suetsugu S, Miki H, Takenawa T (2001) Identification of another actin-related protein (Arp) 2/3 complex binding site in neural Wiskott–Aldrich syndrome protein (N-WASP) that complements actin polymerization induced by the Arp2/3 complex activating (VCA) domain of N-WASP. J Biol Chem 276:33175–33180. doi:10.1074/jbc.M102866200
Peterson JR, Bickford LC, Morgan D, Kim AS, Ouerfelli O, Kirschne MW et al (2004) Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation. Nat Struct Mol Biol 11:747–755. doi:10.1038/nsmb796
Kowalski JR, Egile C, Gil S, Snapper SB, Li R, Thomas SM (2005) Cortactin regulates cell migration through activation of N-WASP. J Cell Sci 118:79–87. doi:10.1242/jcs.01586
Ho HY, Rohatgi R, Lebensohn AM, Le Ma , Li J, Gygi SP, Kirschner MW (2004) Toca-1 mediates Cdc42-dependent actin nucleation by activating the N-WASP-WIP complex. Cell 118:203–216. doi:10.1016/j.cell.2004.06.027
Siliciano JD, Morrow TA, Desiderio SV (1992) Itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2. Proc Natl Acad Sci USA 89:11194–11198. doi:10.1073/pnas.89.23.11194
Acknowledgments
We thank Dr. Matthew J. Schibler of the UCLA Brain Research Institute for assistance with confocal microscopy. We are also grateful to Uma Dandekar, Assistant Director, Sequencing Core and Martin Phillips, Manager, Biochemistry Instrumentation Facility for their help with this study. This work was supported by a grant CA066746 to RC. Colonya C. Calhoun was supported by the NIH Training Grant #T32 DE07296.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Calhoun, C.C., Lu, YC., Song, J. et al. Knockdown endogenous CypA with siRNA in U2OS cells results in disruption of F-actin structure and alters tumor phenotype. Mol Cell Biochem 320, 35–43 (2009). https://doi.org/10.1007/s11010-008-9896-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-008-9896-0